Our group previously showed that the G protein–coupled receptor activates the NF‐κB signal to regulate pancreatic cancer proliferation, angiogenesis and gemcitabine chemoresistance 9. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.